Nature Reviews Rheumatology

Nature Reviews Rheumatology
Title	Nature Reviews Rheumatology
Discipline	Rheumatology
Abbreviation	Nat. Rev. Rheumatol.
Frequency	Monthly
History	2005–present
Impact	(see Impact and Reception)

Nature Reviews Rheumatology Nature Reviews Rheumatology is a monthly peer-reviewed review journal published by Nature Portfolio focusing on rheumatology, clinical practice, and translational research. It synthesizes advances relevant to clinicians and researchers across institutions such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Oxford University Hospitals NHS Foundation Trust, and Karolinska Institutet. The journal situates developments amid broader biomedical contexts exemplified by organizations like the World Health Organization, National Institutes of Health, European Medicines Agency, and Food and Drug Administration.

Overview

Nature Reviews Rheumatology provides high-level reviews, perspectives, and commentary that connect clinical practice at centers including Cleveland Clinic, Toronto General Hospital, and Sheba Medical Center with basic science performed at universities such as Harvard University, University of Oxford, Stanford University, University of Cambridge, and University of California, San Francisco. Articles often reference landmark trials conducted by consortia linked to European League Against Rheumatism, American College of Rheumatology, British Society for Rheumatology, and specialist networks including Rare Diseases Clinical Research Network. The journal is part of the Nature Reviews series alongside titles like Nature Reviews Immunology, Nature Reviews Drug Discovery, and Nature Reviews Disease Primers.

History and Development

Launched in 2005 under the umbrella of Nature Publishing Group during a period of expansion in review journals, the title evolved amid publishing shifts involving entities such as Springer Nature and strategic initiatives paralleling movements at BMJ Group and The Lancet. Early editorial leadership drew contributors from academic centers like University College London, King's College London, Johns Hopkins University School of Medicine, and Yale School of Medicine. The journal's growth tracked advances exemplified by milestone studies from groups at Rheumatology Research Foundation, trials organized through ClinicalTrials.gov, and translational programs connected to Wellcome Trust and Howard Hughes Medical Institute.

Scope and Content

Content spans autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and psoriatic arthritis alongside musculoskeletal conditions addressed in clinics at Royal National Hospital for Rheumatic Diseases and Hospital for Special Surgery. Reviews integrate findings from laboratories like Max Planck Institute for Biochemistry, Cold Spring Harbor Laboratory, and Salk Institute and discuss therapeutics developed by companies including AbbVie, Roche, Novartis, Pfizer, and Johnson & Johnson. The journal situates clinical guidelines from bodies such as National Institute for Health and Care Excellence, American Academy of Neurology (when overlapping topics arise), and European Society for Medical Oncology in the context of basic mechanisms studied at Institut Pasteur and Riken. Coverage includes imaging advances related to systems at Mayo Clinic's Orthopedic Biomechanics Laboratory and biomarker studies influenced by datasets like those curated by UK Biobank.

Editorial Structure and Peer Review

The editorial board comprises experienced editors and academic advisors affiliated with institutions such as Imperial College London, University of Toronto, University of Pennsylvania, Duke University School of Medicine, and Monash University. Editorial processes align with practices common to publishers like Elsevier and Wiley-Blackwell, emphasizing commissioned reviews, invited commentaries, and solicited perspectives. Peer review involves external referees drawn from networks including members of American College of Rheumatology, European League Against Rheumatism, International Society for Pharmacoeconomics and Outcomes Research, and leading investigators from centers such as Johns Hopkins Arthritis Center and Stanford Medicine. Ethical oversight echoes standards promulgated by organizations like the Committee on Publication Ethics and policies comparable to those at The New England Journal of Medicine.

Abstracting and Indexing

The journal is indexed in major databases and services alongside titles indexed in PubMed Central, Scopus, Web of Science, MEDLINE, and citation platforms such as Google Scholar. Its metadata are curated to integrate with institutional repositories at universities including Columbia University, University of Michigan, and University of Sydney, and to appear in cross-referencing systems employed by libraries like the Library of Congress and British Library.

Impact and Reception

Nature Reviews Rheumatology has been cited in guidelines and consensus statements developed by groups such as American College of Rheumatology, European League Against Rheumatism, World Health Organization, and specialist task forces convened by National Institutes of Health panels. The journal's impact factor and citation metrics are tracked alongside comparable review journals like The Lancet Rheumatology, Arthritis & Rheumatology, and Annals of the Rheumatic Diseases and are discussed at conferences such as American College of Rheumatology Annual Meeting, EULAR Congress, and symposia hosted by International Society for Immunology and Inflammation Research.

Notable Publications and Contributions

Notable reviews and commentaries have synthesized landmark trials including those conducted by consortia such as COMET trial, EXPLORER trial, and investigator groups behind therapies approved by the European Medicines Agency and Food and Drug Administration. Influential thematic series have addressed biologic therapies from manufacturers like Amgen and Bristol Myers Squibb, mechanisms elucidated at laboratories like Broad Institute, and translational pathways championed by funders including Wellcome Trust and Bill & Melinda Gates Foundation. The journal has highlighted interdisciplinary collaborations linking rheumatology with specialties at centers such as Dana-Farber Cancer Institute, Mount Sinai Health System, and Massachusetts Eye and Ear that have influenced practice, policy, and research agendas globally.

Category:Medical journals Category:Rheumatology